Experience Smarter Health Insights with Scanbo’s Diagnostic Technology

Mumbai (Maharashtra) [India], December 4: Healthcare is changing as diagnostics move closer to the patient rather than remaining limited to laboratories and hospitals. With rising demand for faster testing and easier access to basic health measurements, point-of-care technology has become an important area of development. Many individuals today rely on multiple appointments, long wait times, and lab-based testing to understand key health indicators, which can delay early decisions and routine monitoring. In response to these challenges, new diagnostic tools are being designed to collect vital health information quickly and without invasive procedures. Scanbo is one such technology developed to support this shift. By using sensor based measurements and artificial intelligence, it offers a way to capture essential health data in a short time and at the point of care, helping both individuals and healthcare providers access information that would otherwise require a lab visit.

Making Diagnostics More Accessible Traditional diagnostic processes often involve several steps before results are available. A person may need to visit a doctor, receive a referral for tests, travel to a lab, provide samples, and then return after results are processed. This sequence can take anywhere from hours to days, depending on location and access to facilities. For many people, especially those in areas where labs are limited, this becomes a barrier to routine health monitoring.

Scanbo’s diagnostic technology aims to simplify this experience. Instead of depending on multiple instruments and lab visits, its system collects health data at the point of care. The approach focuses on delivering essential measurements in minutes, which helps support quicker decision making for both individuals and healthcare professionals. By reducing delays, point of care diagnostics can assist in early monitoring and routine checkups.

The Scanbo D8 as the Starting Point The Scanbo D8 serves as the foundation of the company’s diagnostic platform. It is a compact device designed to perform seven non invasive tests. These include measurements for blood pressure, heart rate, heart rate variability, breathing rate, oxygen saturation, body temperature, and a single lead ECG. Along with these readings, the device also supports a simple finger prick blood glucose test, which remains an essential part of daily monitoring for many individuals.

All of these measurements can be collected in less than five minutes. Once the data is captured, it can be processed to provide an overview of cardiovascular and metabolic indicators. For people who need regular checks or for clinics that handle basic screenings, this model helps reduce reliance on external equipment and laboratory support.

Intelligent Cardiac Analysis with HridaayTaal An important component of Scanbo’s technology is its artificial intelligence platform known as HridaayTaal. This system analyzes cardiac signals to identify patterns and irregularities that may not be visible through simple observation. At present, it supports detection of conditions such as arrhythmia and atrial fibrillation by assessing heart rhythm and variability.

The platform is being developed further to include more advanced analytical capabilities. These include the ability to interpret QRS and PR intervals, corrected QT measurements, and indicators related to sleep apnea. Future stages also plan to support detection of ventricular fibrillation and atrial flutter. By expanding these capabilities over time, the platform moves toward offering deeper insights into cardiac health through non invasive monitoring.

A Roadmap from D8 to D19 While the D8 forms the base of the diagnostic system, Scanbo has outlined a roadmap that builds on it through upcoming devices. The next model, the D12, is projected for 2026 and will introduce four additional blood tests. This expansion is intended to reduce dependence on external labs for common diagnostic requirements.

Following the D12, the D16 is scheduled for 2027 and will add five further blood tests. This step brings the device closer to supporting broader health screenings at the point of care. By 2028, the D19 will complete this progression with three more blood tests, allowing for a wider set of first level diagnostic checks within a single platform.

Together, these devices represent a gradual move toward comprehensive testing outside traditional laboratory environments. The roadmap supports a future in which early checks and routine monitoring can happen more conveniently in community clinics or home based settings.

Digital Integration and Secure Data As diagnostics become more connected, managing health information securely has become increasingly important. Scanbo has introduced a blockchain based healthcare data system designed to support secure and transparent exchange of medical information. This platform is intended for use by patients, providers, and payers, creating a decentralized environment where health data can be accessed when needed while remaining protected from tampering.

The system also supports interoperability, which can help reduce repeated testing when records are not easily available. By maintaining data integrity and controlled access, the platform complements the diagnostic devices and supports coordinated care among different stakeholders in the healthcare ecosystem.

Supporting Regular Health Monitoring Access to timely health insights can play an important role in routine monitoring. For individuals managing conditions such as diabetes or hypertension, frequent testing is often required. Scanbo’s device based approach allows these measurements to be collected without complex procedures or long wait times. By making basic checks easier to conduct, it encourages more consistent monitoring.

For healthcare providers, having data available at the point of care allows them to assess a situation more quickly. This may help in initial decision making and can guide whether further testing or referrals are required. The combination of speed and accessibility is especially valuable in areas where access to full scale laboratories is limited.

Built in India for Local Needs Scanbo’s development and manufacturing take place in India, reflecting the country’s growing capability in medical technology. By designing and assembling devices domestically, the company draws on local engineering talent and aligns with national efforts to strengthen self reliance in healthcare technology. This approach demonstrates that advanced diagnostic solutions can be built within the country to address both local and global healthcare challenges.

The focus on Indian development also supports skill building and contributes to a growing MedTech ecosystem within the nation. As diagnostic tools evolve, domestic capability plays an important role in ensuring that technology remains accessible and relevant to the diverse needs of the population.

Looking Ahead As Scanbo continues to advance its diagnostic technology, the combination of non invasive testing, artificial intelligence, and secure data management forms the foundation of its vision. The progression from the D8 to the D19 highlights a long term plan to expand testing capabilities and make essential diagnostics available in more settings.

With the ability to capture key health indicators quickly and without complex equipment, Scanbo’s platform represents a shift toward more connected and convenient monitoring. As healthcare continues to move toward early detection and preventive care, tools like these support a model where individuals and providers can access information when it matters most.

Conclusion Scanbo’s diagnostic technology offers a pathway to smarter health insights by focusing on speed, accessibility, and non invasive testing. Through the D8 and its upcoming devices, along with the HridaayTaal AI engine and blockchain based data platform, it supports a future where essential health information can be collected and shared more efficiently. By building these solutions in India and focusing on point of care diagnostics, Scanbo contributes to a healthcare model that prioritizes timely information and supports everyday monitoring needs.

(Disclaimer: The above press release comes to you under an arrangement with PNN and PTI takes no editorial responsibility for the same.). PTI PWR

(This content is sourced from a syndicated feed and is published as received. The Tribune assumes no responsibility or liability for its accuracy, completeness, or content.)